Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 4/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.44 |
| ▸ | VEGFA | P15692 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19165160 | 0.92 | HIF1A (0.50) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL19485050 | 0.84 | HIF1A (0.44) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL5265431 | 0.83 | EGFR (0.43) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL18359717 | 0.82 | HIF1A (0.43) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL10360605 | 0.81 | EGFR (0.44) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL6053403 | 0.81 | EGFR (0.41) | ALDH1A1CYP1A2CYP2C19HSD17B10HIF1A | |
| SCHEMBL13318451 | 0.80 | EGFR (0.40) | ALDH1A1CYP1A2CYP2C19HSD17B10HIF1A | |
| SCHEMBL19165801 | 0.79 | HPGD (0.52) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL10809043 | 0.78 | ALDH1A1 (0.46) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 | |
| SCHEMBL10936707 | 0.77 | GLA (0.53) | ALDH1A1HPGDCYP1A2CASP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793482-B2 | Compounds and compositions for delivery of nutrients and micronutrients to plants | SPERO ENERGY, INC. (US) | 2020-10-06 | — | — | US | disclosed |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. | 2018-07-26 | — | — | US | disclosed |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. | 2018-07-26 | — | — | US | disclosed |
| WO-2017004052-A2 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SPERO ENERGY, INC. (US) | 2017-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793482-B2 | Compounds and compositions for delivery of nutrients and micronutrients to plants | SLC19A1, SLC19A2, SLC39A3 | ALDH1A1 2893/4885HPGD 714/4885CYP1A2 1533/4885 |
| US-20180208514-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF NUTRIENTS AND MICRONUTRIENTS TO PLANTS | SLC19A1, SLC19A2, SLC39A3 | ALDH1A1 2893/4885HPGD 714/4885CYP1A2 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.